Related Experiment Videos
Bronchiolitis obliterans: pathogenesis, prevention, and management
1Oklahoma Transplantation Institute, INTEGRIS Baptist Medical Center, Oklahoma City 73112, USA. PARAIL@Integris-Health.com
The American Journal of the Medical Sciences
|March 31, 1998
Summary
Lung transplant recipients face bronchiolitis obliterans syndrome (BOS), an airway obstruction caused by immune injury. Preventing acute rejection is key to reducing BOS prevalence and improving long-term outcomes.
Area of Science:
- Immunology
- Pulmonary Medicine
- Transplantation
Background:
- Lung transplantation offers improved survival but faces long-term challenges.
- Bronchiolitis obliterans (OB) and bronchiolitis obliterans syndrome (BOS) are major causes of graft failure.
- OB/BOS is linked to immune-mediated injury of donor airway epithelium.
Purpose of the Study:
- To review the pathogenesis and risk factors for OB/BOS.
- To discuss current and potential strategies for preventing and treating OB/BOS.
- To highlight the need for further research and multicenter trials.
Main Methods:
- Review of existing literature on lung transplant outcomes and OB/BOS.
- Analysis of the role of acute rejection in OB/BOS development.
- Evaluation of treatment strategies including immunosuppression and infection management.
Main Results:
- Acute rejection is the primary risk factor for OB/BOS.
- Augmented immunosuppression has shown limited success in treating OB/BOS.
- Managing infections in the allograft can be beneficial.
Conclusions:
- Preventing or minimizing acute rejection may decrease OB/BOS incidence.
- New immunosuppressive agents require evaluation in multicenter studies.
- Further research is crucial for effective OB/BOS management.